PubMed HealthSearch

Biomedical subjects

F Praetorius

Publications and source records attributed to F Praetorius.

At least 19 recordsLinked to original sources

[Surgical treatment of temporomandibular joint ankylosis].

Surgical treatment of temporo-mandibular joint (TMJ) ankylosis may be a particularly difficult procedure due to unfavourable anatomic configurations and the proximity of vital structures. Postoperatively, it is followed by an often long and painful period of physiotherapy. The results of treatment of eight patients with TMJ ankylosis are reported. Different methods were used according to age of the patient and the extent of the ankylotic changes. The importance of early treatment is emphasized. This results in less extensive surgery and reduces secondary growth anomalies of the jaws.

Adolescent

A new concept of the pathogenesis of oral mucous cysts based on a study of 200 cases.

A new hypothesis regarding the pathogenesis of mucous cysts of the oral mucosa is proposed. Based upon a histological study of 188 mucous cysts without epithelial lining out of a total of 200 cysts it is claimed that some cysts may not develop in any of the hitherto described ways as intraductal "mucous retention cysts" or extraductal "mucous extravasation cysts" or from destruction of acini due to the pressure of mucous caused by duct obstruction. It is suggested that some of the cysts, that are found to have developed intraglandularly, are caused by traumatic destruction of a large amount of glandular acini ("parenchymal destruction cysts") and continuous secretion from the remaining acini. The mucus from the disintegrated cells forms a pool, which in time is surrounded by a connective tissue capsule that contains remnants of parenchyma from the affected lobule. This parenchyma degenerates, and eventually the cyst shows the same histological picture as the "mucous extravasation cyst". It is argued that the presence of a feeder duct does not necessarily indicate an extravasation cyst, but may be seen in the "parenchymal destruction cysts" as well. Of the 188 cysts examined 20 (11 per cent) were found to develop intraglandularly, and 36 (19 per cent) were considered probably to have developed intraglandularly.

Adolescent

The calcifying epithelial odontogenic tumor. A review of recent literature and report of a case.

The calcifying epithelial odontogenic tumor (CEOT) was described as an entity by Pindborg in 1955. In 1976 a review of the world literature comprising 113 cases was published. Since then, several studies concerned with pathological aspects of this tumor have appeared. Many of these studies have focused on the nature of the amyloid-like material present in CEOT. In this paper a new case is presented and the literature after 1976 is reviewed with respect to histopathological aspects of CEOT.

Amyloidosis

The inflammatory paradental cyst.

The inflammatory paradental cyst has previously been described as the collateral inflammatory cyst, the inflammatory lateral periodontal cyst, the paradental cyst, or the mandibular infected buccal cyst. Clinical, radiographic, and histologic features of 29 inflammatory paradental cysts diagnosed over a 5-year period were studied. The cysts occurred in relation to a partly or fully erupted tooth with a vital pulp. Twenty-seven of the cysts were located in the mandible and the remaining two in the maxilla. The mandibular cysts were in all cases associated with a molar. The observation that the cysts are diagnosed within a few years after tooth eruption and the demonstration of a statistically significant difference (p = 0.001) in age distribution and in the type of tooth involved suggest that eruption is important for the development of the cysts. The consistent finding of a hyperplastic, nonkeratinized stratified squamous epithelium with an intense inflammation in the connective tissue is in accordance with the hypothesis that inflammation is important for the development of these cysts.

Adolescent

Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS).

The effects of recombinant tissue plasminogen activator (rt-PA) and urokinase on patency and early reocclusion of infarct-related coronary arteries were investigated in a single blind, randomized multicenter trial in 246 patients with acute myocardial infarction of less than 6 h duration. Both 70 mg of single chain rt-PA with an initial bolus of 10 mg and 3 million units of urokinase with an initial bolus of 1.5 million units were given intravenously over 90 min. The first angiographic study at the end of the infusion revealed a patent infarct-related artery (Thrombolysis in Myocardial Infarction trial [TIMI] grade 2 or 3) in 69.4% of 121 patients given rt-PA versus 65.8% of 117 patients given urokinase (p = NS). Among patients treated within 3 h from symptom onset a patent infarct-related artery was found in 63.9% of 72 patients given rt-PA versus 70% of 70 patients given urokinase (p = NS). There were five cardiac deaths in each group and one fatal intracranial hemorrhage in the rt-PA group. The in-hospital reinfarction rate was 8.9% versus 13.2% for patients treated with rt-PA and urokinase, respectively. There was no difference in left ventricular function at baseline and follow-up catheterization studies. Both drugs were well tolerated and there was no significant difference in cardiovascular or bleeding complications between the two groups. It is concluded that rt-PA and urokinase in the dosages used provide similar efficacy and safety in the treatment of acute myocardial infarction. Reocclusion during the first 24 h may be less frequent after urokinase treatment.

Adult

[Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].

The effects of recombinant tissue plasminogen activator (rt-PA) and urokinase on patency and early reocclusion of infarct-related coronary arteries were investigated in a single blind, randomised multicenter trial in up to now 125 patients with acute myocardial infarction of less than six hours duration. Both, 70 mg of single-chain rt-PA with an initial bolus of 10 mg, and 3 million U of urokinase with an initial bolus of 1,5 million U were given intravenously over 90 minutes. The first angiogram at the end of the infusion revealed a patent infarct-related artery (TIMI grade 2 or 3) in 68% of 62 patients with rt-PA vs. 63% of 63 patients with urokinase (n.s.). Twenty-four hours later patent infarct-related arteries occurred in the same frequency in the rt-PA group and in the urokinase group (71.5% vs. 74.6%, n.s.), although additional recanalisation procedures in sequence with the first angiography were performed more frequent in the rt-PA group. There were two cardiac deaths in either group. In-hospital reinfarction rate was 9.7% vs. 17.5% for patients treated with rt-PA and urokinase, respectively. Both drugs were well tolerated, no significant difference of cardiovascular or bleeding complications could be observed between the two groups. It is concluded that rt-PA and urokinase in the dosages used provide similar efficiency and safety in the treatment of acute myocardial infarction.

Adult

A new type of human papillomavirus associated with oral focal epithelial hyperplasia.

Lesions from 10 patients suffering from focal epithelial hyperplasia (FEH) of the oral mucosa, including those of 4 Greenlandic Eskimos, were investigated for the presence of human papillomavirus (HPV) DNA sequences by blot hybridization experiments. Two distinct HPVs were detected in the DNA extracted from these lesions, and their genomes were molecularly cloned and characterized. One of these HPVs, detected in 4 patients, was found to be identical with HPV13, whose association with FEH was already known. The other one, detected in 6 patients, was only weakly related to HPV13 and to the other HPVs associated with lesions of the mucous membranes, and constituted a new HPV type, tentatively named HPV32. Lesions from other types of oral papillomas, obtained from 14 additional patients, were also analyzed. Human papillomavirus DNA sequences were detected in the DNA preparations extracted from 5 specimens: HPV6 DNA in a condyloma and in a papilloma, 2 as yet uncharacterized HPV DNAs in 2 papillomas, and HPV32 DNA in a papilloma which showed histologic similarities to FEH. Thus, it seems likely that FEH of the oral mucosa is a disease associated with 2 specific HPVs--HPV13 and HPV32.

Adolescent

[Barodontalgia].

Explore the source record for details and available documents.

Adolescent

Recurrence of the odontogenic keratocyst in relation to clinical and histological features. A 20-year follow-up study of 72 patients.

Seventy-two patients with 75 primary odontogenic keratocysts have been followed from 6 months to 20 years after the primary treatment. Patients with the nevoid basal cell carcinoma syndrome were not included in the material. Fifty-four patients with 57 primary cysts have been followed for 5 years or more, and 18 patients all having a single primary cyst for less. If the number of primary cysts later recurring was related to the number of primary cysts observed for more than 5 years, a recurrence rate of 51% was found. A diagnosis of recurrence was made in 37 cases within a period of 5 years postoperatively and in 10 cases from 5 to 12 years after the operation. Only two of these patients have been followed with regular intervals for the first 5 years postoperatively. The diagnosis of recurrence was in these two cases made 6 and 8 years after the primary treatment. A postoperative follow-up period of 10 years after the last operation is therefore advocated. The occurrence of microcysts and/or islands of odontogneic epithelium in the cyst membrane of 26 nonrecurring cysts, 25 recurring primary cysts and the last recurrence in 14 patients were compared. There were no statistical differences in occurrence of remnants of odontogenic epithelium in the cyst wall between the three groups.

Adolescent

Intraosseous neurofibroma of the jaws.

Two cases of intraosseous neurofibromas of the mandible are presented. Only 25 cases of this tumor have been published previously. Of the present two cases, one was located at the upper border of the mandible, in the left second molar area where the tooth had been extracted 2 years previously. In the second case, the tumor presented itself as a 10 x 2 cm large destruction, mainly following the course of the alveolar nerve from the mandibular foramen to the mental foramen in the right side of the jaw. The mandibular first right molar was missing but the relationship between the extraction of the tooth and the development of the tumor could not be demonstrated. Histologically, the two tumors differed in the way that case 1 showed a conspicuous amount of delicate, wavy fibrils, some of which showed concentric lamellations resembling the pacinian corpuscle but without neurites containing nerve fiber bundles and also demonstrated a slight pleomorphism.

Adult